Nuvve (NASDAQ:NVVE) Cut to Sell at Wall Street Zen
Wall Street Zen cut shares of Nuvve (NASDAQ:NVVE – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday morning. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Nuvve in a research report on Wednesday, October 8th. One equities research analyst has rated […]
Momentus (NASDAQ:MNTS) Cut to Sell at Wall Street Zen
Wall Street Zen cut shares of Momentus (NASDAQ:MNTS – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Momentus in a research note on Wednesday, October 8th. One analyst has rated the stock with a […]
Innovation Beverage Group (NASDAQ:IBG) Cut to Sell at Wall Street Zen
Wall Street Zen downgraded shares of Innovation Beverage Group (NASDAQ:IBG – Free Report) from a hold rating to a sell rating in a research note released on Saturday morning. Innovation Beverage Group Stock Down 1.6% Shares of NASDAQ IBG opened at $1.86 on Friday. Innovation Beverage Group has a 1-year low of $1.48 and a […]
Friedman Industries (NASDAQ:FRD) Cut to Buy at Wall Street Zen
Wall Street Zen cut shares of Friedman Industries (NASDAQ:FRD – Free Report) from a strong-buy rating to a buy rating in a report issued on Saturday. Separately, Weiss Ratings reiterated a “buy (b-)” rating on shares of Friedman Industries in a research note on Monday, December 29th. One research analyst has rated the stock with […]
Bilibili (NASDAQ:BILI) Cut to “Hold” at Wall Street Zen
Wall Street Zen downgraded shares of Bilibili (NASDAQ:BILI – Free Report) from a buy rating to a hold rating in a research note released on Saturday. Other analysts have also issued research reports about the company. Macquarie started coverage on Bilibili in a research note on Tuesday, October 14th. They issued an “outperform” rating and […]
Theravance Biopharma (NASDAQ:TBPH) Cut to Buy at Wall Street Zen
Wall Street Zen lowered shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) from a strong-buy rating to a buy rating in a research report report published on Saturday morning. Other analysts also recently issued research reports about the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Theravance Biopharma in a research note […]
Salarius Pharmaceuticals (NASDAQ:SLRX) Cut to “Sell” at Wall Street Zen
Wall Street Zen cut shares of Salarius Pharmaceuticals (NASDAQ:SLRX – Free Report) from a hold rating to a sell rating in a report published on Saturday morning. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Salarius Pharmaceuticals in a research note on Monday, December 29th. One investment analyst has rated the stock […]
Reliance Global Group (NASDAQ:RELI) Cut to Sell at Wall Street Zen
Wall Street Zen downgraded shares of Reliance Global Group (NASDAQ:RELI – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Reliance Global Group in a report on Wednesday, October 8th. One research analyst has rated […]
MKS (NASDAQ:MKSI) Cut to “Buy” at Wall Street Zen
Wall Street Zen downgraded shares of MKS (NASDAQ:MKSI – Free Report) from a strong-buy rating to a buy rating in a report released on Saturday. A number of other research analysts have also recently commented on MKSI. The Goldman Sachs Group upped their price objective on MKS from $92.00 to $125.00 and gave the company […]
Axcelis Technologies (NASDAQ:ACLS) Cut to “Hold” at Wall Street Zen
Wall Street Zen lowered shares of Axcelis Technologies (NASDAQ:ACLS – Free Report) from a buy rating to a hold rating in a research note published on Saturday. A number of other equities analysts also recently commented on the company. Zacks Research downgraded Axcelis Technologies from a “strong-buy” rating to a “hold” rating in a research […]
Tvardi Therapeutics (NASDAQ:TVRD) Cut to Sell at Wall Street Zen
Wall Street Zen cut shares of Tvardi Therapeutics (NASDAQ:TVRD – Free Report) from a hold rating to a sell rating in a research report sent to investors on Monday morning. A number of other research firms also recently weighed in on TVRD. Piper Sandler cut shares of Tvardi Therapeutics from an “overweight” rating to a […]
OPAL Fuels (NASDAQ:OPAL) Cut to “Sell” at Wall Street Zen
Wall Street Zen lowered shares of OPAL Fuels (NASDAQ:OPAL – Free Report) from a hold rating to a sell rating in a research note issued to investors on Sunday morning. Other analysts have also issued reports about the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of OPAL Fuels in a research report […]
Boxlight (NASDAQ:BOXL) Cut to “Sell” at Wall Street Zen
Wall Street Zen lowered shares of Boxlight (NASDAQ:BOXL – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday morning. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Boxlight in a research report on Tuesday, October 14th. One investment analyst has rated the […]
Sandisk (NASDAQ:SNDK) Cut to “Buy” at Wall Street Zen
Wall Street Zen downgraded shares of Sandisk (NASDAQ:SNDK – Free Report) from a strong-buy rating to a buy rating in a research note published on Saturday. Other analysts have also recently issued research reports about the stock. Benchmark restated a “buy” rating on shares of Sandisk in a research note on Thursday, December 18th. Susquehanna […]
WillScot (NASDAQ:WSC) Cut to Sell at Wall Street Zen
Wall Street Zen cut shares of WillScot (NASDAQ:WSC – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. A number of other brokerages also recently issued reports on WSC. Weiss Ratings reissued a “sell (d+)” rating on shares of WillScot in a research report on Wednesday, […]
Diamondback Energy (NASDAQ:FANG) Cut to “Sell” at Wall Street Zen
Wall Street Zen lowered shares of Diamondback Energy (NASDAQ:FANG – Free Report) from a hold rating to a sell rating in a report issued on Saturday morning. A number of other brokerages also recently commented on FANG. Wells Fargo & Company lifted their target price on shares of Diamondback Energy from $160.00 to $169.00 and […]
Mobile Infrastructure (NASDAQ:BEEP) Cut to “Strong Sell” at Wall Street Zen
Wall Street Zen cut shares of Mobile Infrastructure (NASDAQ:BEEP – Free Report) to a strong sell rating in a research note released on Saturday morning. Several other equities analysts have also recently weighed in on the stock. Barrington Research reaffirmed an “outperform” rating and set a $6.50 price target on shares of Mobile Infrastructure in […]
Anixa Biosciences (NASDAQ:ANIX) Cut to Sell at Wall Street Zen
Wall Street Zen cut shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) from a hold rating to a sell rating in a research report released on Saturday. Several other research firms also recently weighed in on ANIX. Zacks Research downgraded shares of Anixa Biosciences from a “strong-buy” rating to a “hold” rating in a research […]
Galapagos (NASDAQ:GLPG) Cut to Sell at Wall Street Zen
Wall Street Zen downgraded shares of Galapagos (NASDAQ:GLPG – Free Report) from a hold rating to a sell rating in a research note published on Monday morning. Several other research firms have also weighed in on GLPG. Royal Bank Of Canada upped their price objective on Galapagos from $28.00 to $32.00 and gave the company […]
JX Luxventure Group (NASDAQ:JXG) Cut to “Sell” at Wall Street Zen
Wall Street Zen downgraded shares of JX Luxventure Group (NASDAQ:JXG – Free Report) from a hold rating to a sell rating in a research report report published on Sunday morning. Separately, Weiss Ratings reissued a “sell (d)” rating on shares of JX Luxventure Group in a report on Wednesday, October 8th. One research analyst has […]
Humacyte (NASDAQ:HUMA) Cut to Sell at Wall Street Zen
Wall Street Zen downgraded shares of Humacyte (NASDAQ:HUMA – Free Report) from a hold rating to a sell rating in a research note issued to investors on Sunday morning. A number of other research firms have also issued reports on HUMA. Weiss Ratings reiterated a “sell (d-)” rating on shares of Humacyte in a research […]
Starz Entertainment (NASDAQ:STRZ) Cut to Sell at Wall Street Zen
Wall Street Zen lowered shares of Starz Entertainment (NASDAQ:STRZ – Free Report) from a hold rating to a sell rating in a report released on Sunday. A number of other research firms have also recently commented on STRZ. Baird R W raised shares of Starz Entertainment to a “hold” rating in a research note on […]
last updated on 6 Jan 13:44